(Q34635845)

3 August 2017

1 reference

title

Analysis of exhaled breath condensate for monitoring airway inflammation (English)

1 reference

3 August 2017

0 references

1 reference

1

Paolo Montuschi

1 reference

3 August 2017

Peter J Barnes

2

1 reference

3 August 2017

1 May 2002

1 reference

Trends in Pharmacological Sciences

3 August 2017

1 reference

3 August 2017

23

1 reference

3 August 2017

232-237

1 reference

3 August 2017

5

1 reference

Use of bronchoalveolar lavage in humans--past necessity and future imperative

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Biopsy markers of airway inflammation and remodelling

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Update on sputum methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Role of exhaled nitric oxide in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Collection and analysis of exhaled breath condensate in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Exhaled markers of pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Increased nitrotyrosine in exhaled breath condensate of patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

The isoprostanes in biology and medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Exhaled leukotrienes and prostaglandins in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Leukotrienes and Inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Bronchoprotective role for endogenous prostaglandin E2

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Exhalation of H2O2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Combined Use of Exhaled Hydrogen Peroxide and Nitric Oxide in Monitoring Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Elevated Levels of Expired Breath Hydrogen Peroxide in Bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Expired hydrogen peroxide in breath condensate of cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Hydrogen peroxide in exhaled air of healthy children: reference values.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Endogenous airway acidification. Implications for asthma pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Detection of nonvolatile macromolecules in breath. A possible diagnostic tool?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

Detection of IL-10 in the exhaled breath condensate, plasma and tissue during ischemia-reperfusion injury in experimental lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902020-5

7 January 2021

10.1016/S0165-6147(02)02020-5

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12008001